نتایج جستجو برای: mycn

تعداد نتایج: 1228  

Journal: :Cancer research 2004
Hong Wei Yang Jeffery L Kutok Nam Hyuk Lee Hui Ying Piao Christopher D M Fletcher John P Kanki A Thomas Look

The zebrafish model organism has been used extensively for studies of genetic pathways in development, indicating its potential applicability to cancer. Here we show that targeted expression of MYCN in cells of the pancreatic islet induces neuroendocrine carcinoma. Four transgenic fish developed abdominal tumors between 4 and 6 months of age, and histologic analysis revealed lobulated arrangeme...

Journal: :Frontiers in bioscience 2011
Elizabeth A Beierle

Neuroblastoma is the most common extracranial solid tumor of childhood. This tumor is characterized by poor survival, especially when it features amplification of the MYCN oncogene. The ability for human cancers to propagate is marked by their ability to invade and metastasize to distant sites. Focal adhesion kinase (FAK) is a key tyrosine kinase involved in the survival and metastasis of a num...

Journal: :Medical and pediatric oncology 2000
H Goto N Keshelava K K Matthay J N Lukens R B Gerbing D O Stram R C Seeger C P Reynolds

BACKGROUND AND PROCEDURE MRP1 expression by neuroblastomas was evaluated by Northern blot analysis in 21 cell lines and 90 primary untreated tumors. Cytotoxicity assay in cell lines was performed for five anticancer drugs used in treating neuroblastoma. RESULTS MRP1 expression did not correlate with drug resistance or with MYCN RNA expression in cell lines. MRP1 expression was higher in drug-...

Journal: :Cancer cell 2002
Bernd Berwanger Oliver Hartmann Eckhard Bergmann Sandra Bernard Dirk Nielsen Michael Krause Ali Kartal Daniel Flynn Ruprecht Wiedemeyer Manfred Schwab Helmut Schäfer Holger Christiansen Martin Eilers

Tumor stage, age of patient, and amplification of MYCN predict disease outcome in neuroblastoma. To gain insight into the underlying molecular pathways, we have obtained expression profiles from 94 primary neuroblastoma specimens. Advanced tumor stages show a characteristic expression profile that includes downregulation of multiple genes involved in signal transduction through Fyn and the acti...

Journal: :Cancer research 2013
Satoshi Kishida Ping Mu Shin Miyakawa Masatoshi Fujiwara Tomoyuki Abe Kazuma Sakamoto Akira Onishi Yoshikazu Nakamura Kenji Kadomatsu

Midkine is a heparin-binding growth factor highly expressed in various cancers, including neuroblastoma, the most common extracranial pediatric solid tumor. Prognosis of patients with neuroblastoma in which MYCN is amplified remains particularly poor. In this study, we used a MYCN transgenic model for neuroblastoma in which midkine is highly expressed in precancerous lesions of sympathetic gang...

Journal: :European journal of medical genetics 2012
Chih-Ping Chen Shuan-Pei Lin Schu-Rern Chern Peih-Shan Wu Shuenn-Dyh Chang Shu-Hang Ng Yu-Peng Liu Jun-Wei Su Wayseen Wang

We report a 26-month-old girl with profound hearing impairment, microcephaly, psychomotor retardation, short palpebral fissures, hypertelorism, epicanthic folds, a broad nasal bridge, anteverted nostrils, large low-set ears, micrognathia, brachymesophalangy of the second and the fifth fingers, clinodactyly of bilateral fifth fingers and a wide interdigital space between the first and the second...

2013
Anastasia Wyce Gopinath Ganji Kimberly N. Smitheman Chun-wa Chung Susan Korenchuk Yuchen Bai Olena Barbash BaoChau Le Peter D. Craggs Michael T. McCabe Karen M. Kennedy-Wilson Lydia V. Sanchez Romain L. Gosmini Nigel Parr Charles F. McHugh Dashyant Dhanak Rab K. Prinjha Kurt R. Auger Peter J. Tummino

BET family proteins are epigenetic regulators known to control expression of genes involved in cell growth and oncogenesis. Selective inhibitors of BET proteins exhibit potent anti-proliferative activity in a number of hematologic cancer models, in part through suppression of the MYC oncogene and downstream Myc-driven pathways. However, little is currently known about the activity of BET inhibi...

2011
Åslaug Helland Michael S. Anglesio Joshy George Prue A. Cowin Cameron N. Johnstone Colin M. House Karen E. Sheppard Dariush Etemadmoghadam Nataliya Melnyk Anil K. Rustgi Wayne A. Phillips Hilde Johnsen Ruth Holm Gunnar B. Kristensen Michael J. Birrer Richard B. Pearson Anne-Lise Børresen-Dale David G. Huntsman Anna deFazio Chad J. Creighton Gordon K. Smyth David D. L. Bowtell

Molecular subtypes of serous ovarian cancer have been recently described. Using data from independent datasets including over 900 primary tumour samples, we show that deregulation of the Let-7 pathway is specifically associated with the C5 molecular subtype of serous ovarian cancer. DNA copy number and gene expression of HMGA2, alleles of Let-7, LIN28, LIN28B, MYC, MYCN, DICER1, and RNASEN were...

2014
ANDRES SILVA JENNIE WANG SARAH LOMAHAN TUAN-ANH TRAN LAURA GRENLIN AKIKO SUGANAMI YUTAKA TAMURA NAOHIKO IKEGAKI

OSU-03012, a 3-phosphoinositide-dependent kinase-1 (PDK1) inhibitor, destabilizes MYCN and MYC proteins in neuroblastoma cells. However, AKT phosphorylation is barely detectable in neuroblastoma cells under normal culture conditions whether treated with OSU-03012 or not. This observation suggests that PDK1 is not the main target of OSU-03012 to destabilize MYC and MYCN in neuroblastoma cells. I...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید